Investigators conducted a population-based study in which a survey was deployed to assess the impact of the COVID-19 pandemic on mental health and well-being.
The approval was based on the ASPIRE I and II trials that compared the efficacy and safety of esketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, to placebo in 449 adults with moderate to severe MDD who had active suicidal ideation and intent.
Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression.
A team of investigators assessed the impact of anxiety and mood disorders on treatment with anti-tumor necrosis factor agents in individuals with inflammatory bowel disease.
The case of an older woman who underwent treatment with accelerated intermittent theta burst stimulation for major depressive disorder is reported.
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Therapists trained in IPSRT examined patients’ interpersonal patterns and social rhythms, as well as how they affected mood symptoms and interpersonal functioning.
Mothers who have children with MS have a higher prevalence of physical conditions, as well as a higher prevalence of mood and anxiety disorders.
Depression and anxiety are common in patients with rheumatoid arthritis.
Among patients with borderline personality disorder, symptom severity was associated with less stability and lower relative amplitude. Impulsivity and mood instability were each negatively correlated with interdaily stability and relative amplitude.